What Influences the Willingness of Blacks and African Americans to Enroll in Preclinical Alzheimer’s Disease Biomarker Research? A Qualitative Vignette Analysis

BACKGROUND: Alzheimer’s disease (AD) begins with an asymptomatic “preclinical” phase, in which abnormal biomarkers indicate risk for developing cognitive impairment. Research is increasingly focused on validating biomarkers to improve reliable diagnosis and timely clinical treatment of AD. Most prec...

Descripción completa

Detalles Bibliográficos
Autores principales: Ketchum, Fred B., Erickson, Claire M., Chin, Nathaniel A., Gleason, Carey E., Lambrou, Nickolas H., Benton, Susan Flowers, Clark, Lindsay R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198766/
https://www.ncbi.nlm.nih.gov/pubmed/35466937
http://dx.doi.org/10.3233/JAD-215521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198766/
https://www.ncbi.nlm.nih.gov/pubmed/35466937
http://dx.doi.org/10.3233/JAD-215521

Ejemplares similares